Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Withdrawal Notice: Lycorine's Role in Angiogenesis Inhibition via PDGFRα Interaction

  • By

  • Fei Lv

  • XiaoQi Li

  • Ying Wang

  • September 11, 2026

Share

Clinical Scorecard: Withdrawal Notice: Lycorine's Role in Angiogenesis Inhibition via PDGFRα Interaction

At a Glance

CategoryDetail
ConditionAngiogenesis Inhibition
Key MechanismsPDGFRα Interaction
Target PopulationNot specified
Care SettingResearch context

Key Highlights

  • Article retracted due to data integrity concerns
  • Overlap in data presentation noted among conditions
  • Authors did not address post-publication concerns
  • Editors lost confidence in the article's data and conclusions
  • No response from authors regarding retraction

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Not applicable

          Not applicable

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Retraction Note: Lycorine inhibits angiogenesis by docking to PDGFRα

            • by Fei Lv, XiaoQi Li, Ying Wang

            • September 11, 2026

            Related Content

            Case Report: Donor-derived early T-cell precursor acute lymphoblastic leukemia following an allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia

            Comment on “Life’s essential 8 and specific cancer risk and mortality in men and women: a population-based cohort analysis of 332,417 United Kingdom participants” and the inclusion of sleep in cancer focused guidelines

            Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling